IL-6 as a predictor of survival rate in liver metastatic breast cancer patients with Covid-19 infection: A case series
Description
CONCLUSION: Elevated levels of IL-6 can be a prognostic factor of the survival rate of metastatic breast cancer patients during the treatment of Covid-19 infection.
